ACC: Treat-to-Target LDL-C Strategy Noninferior to High-Intensity Statins
Elana Gotkine
TUESDAY, March 7, 2023 (HealthDay News) -- For patients with coronary artery disease, a treat-to-target low-density lipoprotein cholesterol (LDL-C) strategy is noninferior to…